These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1983785)

  • 1. Adjunctive fluoxetine improves global function in chronic schizophrenia.
    Goldman MB; Janecek HM
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):429-31. PubMed ID: 1983785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment.
    Nolfe G; Milano W; Zontini G; Petrella C; De Rosa M; Rundle-Smith S; Nolfe G
    J Psychiatr Pract; 2010 Jul; 16(4):235-42. PubMed ID: 20644358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.
    Spina E; De Domenico P; Ruello C; Longobardo N; Gitto C; Ancione M; Di Rosa AE; Caputi AP
    Int Clin Psychopharmacol; 1994; 9(4):281-5. PubMed ID: 7868850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW; Shin IS; Kim JM; Yang SJ; Hwang MY; Yoon JS
    J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
    Leiderman E; Zylberman I; Zukin SR; Cooper TB; Javitt DC
    Biol Psychiatry; 1996 Feb; 39(3):213-5. PubMed ID: 8837983
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia.
    al-Semaan Y
    Can J Psychiatry; 1996 Sep; 41(7):484-5. PubMed ID: 8884041
    [No Abstract]   [Full Text] [Related]  

  • 8. Ideal and reality of neuroleptic relapse prevention.
    Kissling W
    Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjunctive carbamazepine or lithium carbonate in therapy-resistant chronic schizophrenia.
    Simhandl C; Meszaros K; Denk E; Thau K; Topitz A
    Can J Psychiatry; 1996 Jun; 41(5):317. PubMed ID: 8793154
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjunctive clonazepam in the treatment of chronic schizophrenia.
    Herrera JM; Alvarez WA; Freinhar JP; Lawson WB; Sramek JJ
    Int J Psychosom; 1991; 38(1-4):17-20. PubMed ID: 1685726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.
    Feifel D; Macdonald K; Nguyen A; Cobb P; Warlan H; Galangue B; Minassian A; Becker O; Cooper J; Perry W; Lefebvre M; Gonzales J; Hadley A
    Biol Psychiatry; 2010 Oct; 68(7):678-80. PubMed ID: 20615494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate for refractory schizophrenia.
    Millson RC; Owen JA; Lorberg GW; Tackaberry L
    Am J Psychiatry; 2002 Apr; 159(4):675. PubMed ID: 11925318
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome.
    Canuso CM; Goldman MB
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):86-90. PubMed ID: 9990561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.
    Spina E; Avenoso A; Facciolà G; Fabrazzo M; Monteleone P; Maj M; Perucca E; Caputi AP
    Int Clin Psychopharmacol; 1998 May; 13(3):141-5. PubMed ID: 9690983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.
    Goff DC; Brotman AW; Waites M; McCormick S
    Am J Psychiatry; 1990 Apr; 147(4):492-4. PubMed ID: 1969245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
    Dassa D; Lacambre M; Vacheron MN
    Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
    [No Abstract]   [Full Text] [Related]  

  • 17. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.
    Smith RC
    Arch Gen Psychiatry; 1994 May; 51(5):427-9. PubMed ID: 7910013
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: a double-blind, randomized, placebo-controlled clinical trial.
    Ghafari E; Fararouie M; Shirazi HG; Farhangfar A; Ghaderi F; Mohammadi A
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):172-6. PubMed ID: 23302446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
    Viala A; Aymard N; Leyris A; Caroli F
    Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.